Vanguard Group Inc Medicinova Inc Transaction History
Vanguard Group Inc
- $6.44 Trillion
- Q3 2025
A detailed history of Vanguard Group Inc transactions in Medicinova Inc stock. As of the latest transaction made, Vanguard Group Inc holds 700,385 shares of MNOV stock, worth $1.07 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
700,385
Previous 686,577
2.01%
Holding current value
$1.07 Million
Previous $899,000
1.89%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding MNOV
# of Institutions
25Shares Held
5.03MCall Options Held
0Put Options Held
0-
Essex Woodlands Management, Inc. The Woodlands, TX1.11MShares$1.69 Million0.45% of portfolio
-
Black Rock Inc. New York, NY695KShares$1.06 Million0.0% of portfolio
-
Citigroup Inc594KShares$908,9070.0% of portfolio
-
Geode Capital Management, LLC Boston, MA530KShares$810,4440.0% of portfolio
-
Ubs Group Ag222KShares$340,0680.0% of portfolio
About MEDICINOVA INC
- Ticker MNOV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,046,200
- Market Cap $75M
- Description
- MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...